Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share capital and reserves (Tables)

v3.23.1
Share capital and reserves (Tables)
12 Months Ended
Dec. 31, 2022
Share capital and reserves  
Summary of changes in warrants

​

​

​

​

​

​

​

​

    

​

    

Weighted  

​

​

Number of 

​

Average

​

    

Warrants

    

Exercise price

Balance, December 31, 2020

​

1,555,317

​

$

2.94

Granted – February 9, 2021

​

2,085,687

​

$

4.70

Granted – October 15, 2021

 

2,431,900

 

​

US$4.77

Granted – October 15, 2021

 

910,000

 

​

(1)US$1.17

Exercised

 

(640,012)

​

$

3.34

Expired

 

(1,215,816)

​

$

2.94

Balance, December 31, 2021

 

5,127,076

​

$

5.58

Granted – October 7, 2022

 

5,000,000

​

​

US$1.22

Balance, December 31, 2022

 

10,127,076

​

$

3.34

Schedule of information on warrants outstanding

The following table summarizes information on warrants outstanding at December 31, 2022:

​

​

​

​

​

​

​

​

    

​

    

​

    

Remaining 

​

​

Number 

​

​

​

Contractual 

Exercise Price

    

Outstanding

    

Expiry date

    

Life

$4.70

​

1,785,176

​

February 9, 2026

​

3.11 years

US$4.77

​

2,431,900

​

October 15, 2026

​

3.79 years

US$1.17

 

910,000

​

October 15, 2026

 

3.79 years

US$1.22

 

5,000,000

​

October 7, 2027

 

4.77 years

​

Schedule of the changes in pre-funded warrants

​

​

​

​

​

​

​

    

​

    

Weighted

​

​

Number of 

​

Average 

​

    

Warrants

    

 Exercise price

Balance, December 31, 2020 and 2021

​

—

​

—

Granted – October 7, 2022

 

3,600,000

 

US$0.0001

Exercised

 

(641,000)

 

US$0.0001

Balance, December 31, 2022

 

2,959,000

 

US$0.0001

​

Schedule of changes in finders' warrants

​

​

​

​

​

​

​

​

    

​

​

Weighted  

​

​

Number of 

​

Average

​

    

Warrants

    

Exercise price

Balance, December 31, 2020

​

11,896

​

$

1.64

Granted – February 9, 2021

​

58,288

​

$

4.70

Granted – October 15, 2021

 

145,300

​

​

US$4.77

Exercised

 

(11,571)

​

$

1.87

Expired

 

(1,193)

​

$

1.64

​

​

​

​

​

​

Balance, December 31, 2021

 

202,720

​

$

5.66

Granted – October 7, 2022 – finders’ warrants

 

250,000

​

​

US$1.22

Balance, December 31, 2022

 

452,720

​

$

3.58

​

Schedule of information on finders' warrants outstanding

The following table summarizes information on finders’ warrants outstanding at December 31, 2022:

​

​

​

​

​

​

​

​

    

​

    

​

    

Remaining

​

​

Number

​

​

​

Contractual

Exercise Price

​

Outstanding

​

Expiry date

​

Life

$4.70

​

57,420

​

February 9, 2026

​

3.11 years

US$4.77

​

145,300

​

October 15, 2026

​

3.79 years

US$1.22

​

250,000

​

October 7, 2027

​

4.77 years

​

Schedule of fair value of stock options granted was estimated on the date of grant using the Black-Scholes mode

​

​

​

​

​

​

​

​

    

2022

    

2021

 

Dividend yield

 

Nil

 

Nil

​

Annualized volatility

 

100

%  

100

%

Risk-free interest rate

 

1.44%-3.32

%  

0.36% - 1.19

%

Expected life

 

5 years

 

5 years

​

​

Schedule of the changes in stock options for the years

​

​

​

​

​

​

​

​

    

​

    

Weighted 

​

​

Number of 

​

Average

​

    

Options

    

 Exercise price

Balance, December 31, 2020

​

464,207

​

$

3.29

Granted – January 11, 2021

​

59,624

​

$

3.29

Granted – May 12, 2021

​

42,588

​

$

1.88

Granted – June 16, 2021

 

21,294

​

$

1.76

Granted – July 14, 2021

 

63,882

​

$

2.41

Granted – December 21, 2021

 

86,495

​

$

2.54

Exercised

 

(51,106)

​

$

1.64

Expired

 

(80,917)

​

$

3.40

Balance, December 31, 2021

 

606,067

​

$

3.10

Granted – January 12, 2022

 

127,500

​

$

2.54

Granted – June 6, 2022

 

394,822

​

$

1.60

Granted – November 25, 2022

 

70,000

​

$

1.38

Expired

 

(44,070)

​

$

3.19

Balance, December 31, 2022

 

1,154,319

​

$

2.42

Vested and exercisable, December 31, 2022

 

872,055

​

$

2.58

​

Schedule of information on stock options outstanding and contractual remaining life

The following table summarizes information on stock options outstanding at December 31, 2022:

​

​

​

​

​

​

​

​

​

​

    

Number 

    

Number 

​

​

    

Remaining 

Exercise Price

    

Outstanding

    

Exercisable

    

Expiry Date

    

Contractual Life

$5.87

​

114,984

​

114,984

​

March 19, 2023

​

0.21 years

$5.87

​

21,294

​

21,294

​

November 5, 2023

​

0.85 years

$1.64

​

170,354

​

150,479

​

June 23, 2025

​

2.48 years

$2.82

 

12,776

 

12,776

​

August 27, 2025

 

2.66 years

$3.29

 

59,624

 

59,624

​

January 11, 2026

 

3.03 years

$1.88

 

21,294

 

21,294

​

May 12, 2026

 

3.36 years

$1.76

 

21,294

 

21,294

​

June 16, 2026

 

3.46 years

$2.41

 

63,882

 

30,166

​

July 14, 2026

 

3.54 years

$2.54

 

86,495

 

86,495

​

December 21, 2026

 

3.98 years

$2.54

 

117,500

 

35,902

​

January 12, 2027

 

4.04 years

$1.60

 

394,822

 

315,803

​

June 6, 2027

 

4.43 years

$1.38

 

70,000

 

1,944

​

November 25, 2027

 

4.90 years

​

 

1,154,319

 

872,055

​

​

​

​

​

Schedule of the derivative warrant liabilities

​

​

​

​

​

Balance at December 31, 2020

    

$

—

Warrants issued February 9, 2021

​

 

5,358,000

Warrants exercised

​

 

(425,900)

Fair value reclassified to reserves

​

 

(4,460,000)

Warrants issued October 15, 2021

​

 

7,425,000

Fair value adjustment

​

 

(3,299,768)

Balance at December 31, 2021

​

$

4,597,332

Warrants issued October 7, 2022

​

 

5,093,593

Fair value adjustment

​

 

(4,470,276)

Balance at December 31, 2022

​

$

5,220,649

​

Schedule of significant on assumptions used in determining the fair value of the derivative warrant liabilities

​

​

​

​

​

​

​

​

    

December 31, 

    

December 31, 

 

​

    

2022

    

2021

​

Share price

​

$0.81

​

$2.05

 

Risk-free interest rate

 

3.55

%  

1.23

%

Dividend yield

 

—

%  

—

%

Expected volatility

 

100

%  

100

%

Remaining term (in years)

 

3.8-4.8

 

4.8

​

​